Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study is meant to assess the effectiveness of idebenone on neurological outcome measures
in patients with Friedreich's Ataxia over a 6 months period.